CD8+ T-cell infiltration in tumor is associated with local immune activation and response to immune checkpoint therapy (Tumeh et al., 2014), and PD-L1 expression is a marker of response to PD-1 blockade (Khunger et al., 2017). Here, CD8A is linked to neoplasm.